There are Six Stocks That Hedge Funds and Mutual Funds are Both Overweight - and SpaceX is One

Dow Jones
昨天

Hedge funds and mutual funds were overweight SpaceX, according to a Goldman Sachs analysis of 13-F filings.

SpaceX, trading at 93 times next year's estimated earnings, seems hardly the stock to unite both short-term-focused hedge-fund managers and more long-term-oriented mutual-fund managers.

Yet according to Goldman Sachs' exhaustive look at the $10 trillion of stock-market positions through 13-F filings at the Securities and Exchange Commission, SpaceX $(SPCX)$ is one of six stocks that both sets of portfolio managers are overweight on, relative to the S&P 500.

SpaceX went public on June 12, near the end of the second quarter that 13-F filings tracked.

The others: Boeing $(BA)$, Capital One Financial $(COF)$, Mastercard $(MA)$, Thermo Fisher Scientific $(TMO)$ and Visa (V).

It's an odd grouping of six stocks, but one that's handily outperformed the S&P 500 SPX this year, rising 29% vs. just 16% for the index, according to Goldman's calculations.

Goldman strategists led by Ben Snider say "shared favorites," since 2013, have delivered an annual return of 17%, though they tend to be both volatile and trade at bigger price-to-earnings premium.

These particular six stocks don't have much in common, though two - Visa and Mastercard - operate in a near-duopoly of the global payments processing market, while Boeing is in a near duopoly with France's Airbus (FR:AIR) in civil aviation.

Despite its heady valuation, SpaceX is the dominant player in both reusable commercial rockets and global satellite internet.

The Goldman analysis also found that hedge funds were more exposed to stocks benefiting from artificial intelligence, while both sets of managers are overweight the financial sector XLF, for only the third time since Goldman started tracking that.

-Steve Goldstein

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10